Researchers in London and Spain, in a prospective, randomized, study of long-term (3 year) effects of first- and second-generation antipsychotics on neurocognition in 79 patients following a “first episode of schizophrenia spectrum disorders”, find that “haloperidol, olanzapine, and risperidone have not demonstrated substantial neurocognitive effectiveness.” Results appeared online in Psychopharmacology on March 2, 2013.
Article →Ayesa-Arriola, R., Rodriguez-Sanchez, J., Perez-Iglesias, R., et al; Long-Term (3-Year) Neurocognitive Effectiveness of Antipsychotic Medications in First-Episode Non-Affective Psychosis. Psychopharmacology. Online March 2, 2013
Haloperidol, olanzapine and risperidone did definitely NOT help my son as far as cognition was concerned. These meds actually stopped him from reasoning out his problems. Once he took himself off the antipsychotic medication, he could see straight away the absurdity of his assumptions: that the whole British police force was after him and that spies were lurking everywhere. These meds actually kept him trapped in the delusional world he had created during fever and infection.
Report comment
Wow! That’s like saying “getting beaten up in front of a large crowd of guffawing onlookers does nothing for your self-esteem”. They needed to do research to work that one out?
Report comment
The whole purpose of these drugs is to create Neurocogntive decline, now they do research to say it doesn’t improve. I guess its more proof to support what they are doing – creating neurocognitive decline.
Report comment
‘The study also underscores the importance of exploring new drugs for the treatment of cognitive impairments and associated functional disabilities in schizophrenia.’
‘Schizophrenia’ costs the UK £36,000 per sufferer per year. The Medical Treatment eventually kills the patient. New drugs are killing people quicker.
My own experience of longterm Recovery and return to Taxpaying Status was through the Talking Treatments.
Report comment